RESEARCHER PROFILE

Barbara B. Bendlin

← Back to University of Wisconsin–Madison

B

University of Wisconsin–Madison

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatmentsAdvanced Neuroimaging Techniques and ApplicationsFunctional Brain Connectivity StudiesCancer-related cognitive impairment studies

Barbara B. Bendlin works in Dementia and Cognitive Impairment Research, Alzheimer's disease research and treatments, Advanced Neuroimaging Techniques and Applications, Functional Brain Connectivity Studies, Cancer-related cognitive impairment studies. Recorded institutional associations include University of Wisconsin–Madison, Harvard University, Alzheimer’s Disease Neuroimaging Initiative.

646Publications
15,158Citations
64H-index

Inclusion identifies researchers whose recorded research contributions may inform their university’s understanding of its research community. It does not rank individual research quality or establish current employment.

Selected research works

Up to 100 highly cited works; DOI links open the original research. Counts reflect the collected record, not real-time citation totals.

  1. Gut microbiome alterations in Alzheimer’s disease

    2017 · 2,109 citations
  2. The gut microbiota-derived metabolite trimethylamine N-oxide is elevated in Alzheimer’s disease

    2018 · 467 citations
  3. Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle–Aged Adults at Risk for Alzheimer Disease

    2015 · 414 citations
  4. Biomarkers for Alzheimer’s disease—preparing for a new era of disease-modifying therapies

    2020 · 377 citations
  5. Longitudinal changes in patients with traumatic brain injury assessed with diffusion-tensor and volumetric imaging

    2008 · 336 citations
  6. The Wisconsin Registry for Alzheimer's Prevention: A review of findings and current directions

    2017 · 316 citations
  7. Insulin resistance predicts brain amyloid deposition in late middle‐aged adults

    2014 · 262 citations
  8. Association of Amyloid Pathology With Myelin Alteration in Preclinical Alzheimer Disease

    2016 · 252 citations
  9. Amyloid burden is associated with self-reported sleep in nondemented late middle-aged adults

    2015 · 242 citations
  10. Physical activity attenuates age-related biomarker alterations in preclinical AD

    2014 · 226 citations
  11. Poor sleep is associated with CSF biomarkers of amyloid pathology in cognitively normal adults

    2017 · 225 citations
  12. Insulin Resistance, Brain Atrophy, and Cognitive Performance in Late Middle–Aged Adults

    2012 · 219 citations
  13. Amyloid burden and neural function in people at risk for Alzheimer's Disease

    2013 · 217 citations
  14. Association of Neighborhood-Level Disadvantage With Alzheimer Disease Neuropathology

    2020 · 201 citations
  15. White Matter in Aging and Cognition: A Cross-Sectional Study of Microstructure in Adults Aged Eighteen to Eighty-Three

    2010 · 187 citations
  16. Association of Neighborhood-Level Disadvantage With Cerebral and Hippocampal Volume

    2020 · 162 citations
  17. Measuring longitudinal cognition: Individual tests versus composites

    2018 · 143 citations
  18. Low cerebral blood flow is associated with lower memory function in metabolic syndrome

    2013 · 139 citations
  19. Occupational Complexity and Cognitive Reserve in a Middle-Aged Cohort at Risk for Alzheimer's Disease

    2015 · 138 citations
  20. An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuum

    2020 · 138 citations
  21. Associations between white matter microstructure and amyloid burden in preclinical Alzheimer's disease: A multimodal imaging investigation

    2014 · 136 citations
  22. Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer’s Disease

    2016 · 131 citations
  23. White matter is altered with parental family history of Alzheimer's disease

    2010 · 129 citations
  24. Regional white matter hyperintensities: aging, Alzheimer's disease risk, and cognitive function

    2013 · 126 citations
  25. Microstructural white matter alterations in preclinical Alzheimer’s disease detected using free water elimination diffusion tensor imaging

    2017 · 125 citations

← Return to the university profile